News

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age. The findings suggest that concerns related to pregnancy may lead to delayed or reduced use of disease-modifying treatments (DMTs), even before pregnancy becomes a consideration. [...]

An NHS England programme announced this week will help to protect people with Parkinson's from potential harm associated with poor access to time critical medication, campaigners say. NHS England has committed to a three year Medicines Safety Improvement Programme focused on time critical medication. The move follows a long campaign from charity Parkinson's UK over [...]

By Sarah Lake, research assistant, Charlotte Giblin, assistant psychologist and Dr Penny Trayner, clinical neuropsychologist and founder and CEO of Goal Manager. Through advancements in technology, quantitative data in rehabilitation is becoming increasingly available. Considering this, it is important to reflect on the literature around quantitative data in rehabilitation to outline the benefits of these [...]

A novel neurotechnology treatment known as deep brain stimulation (DBS) can benefit patients with neurological disorders, but it involves surgical procedures with potential risks. Assessing the risk-benefit tradeoffs and the ethics in making decisions about whether to begin such treatments and when can be tricky for both patients and clinicians. Laura Cabrera, associate professor of [...]

A new study has shown that stroke survivors are more likely to experience abnormal sleep patterns - such as sleeping too much or not enough - compared to those who have not had a stroke. For the study, participants were asked about their sleep patterns, such as how much sleep they usually get at night [...]

Neurocrine Biosciences has announced that its ERUDITE™ Phase 2 clinical study of investigational compound luvadaxistat (NBI-1065844) failed to meet its primary endpoint as a potential treatment to improve cognitive impairment in patients with schizophrenia. Luvadaxistat failed to replicate the cognitive endpoints data seen in the earlier INTERACT™ study. Researchers say this was due in part [...]

A new study has found that ethical and legal guidance is not keeping up with the fast pace of development for highly accessible, portable neuroimaging. The research team found that developers of portable neuroimaging have failed to formally address ethical, legal and social issues (ELSI) as they designed and deployed portable magnetic resonance imaging (MRI) [...]

Lord Darzi's landmark NHS Review contains encouraging suggestions for spinal cord injury survivors - including its emphasis on integrating health and social care. That is according to the Spinal Injuries Association (SIA), which has welcomed a number of points made in the report. Lord Darzi, an independent peer and an NHS surgeon, published his NHS [...]

A novel study has explored the effects of delayed feedback on learning in individuals with moderate-to-severe traumatic brain injury, finding that delayed feedback may engage brain regions responsible for memory retrieval and confidence. The goal of the study was to assess the effects of delayed vs. immediate performance feedback on learning in individuals with traumatic [...]

A new study has reported a novel treatment that can be administered after a traumatic brain injury that prevents progression to chronic neurodegeneration. Violent blows or jolts to the head can cause traumatic brain injury (TBI). There are currently about five million people in the U.S. living with chronic neurodegeneration and related impairments due to [...]